Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids

NCT01355874 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

403

Enrollment

INDUSTRY

Sponsor class

Stopped The primary endpoint was not met on the double blind data

Conditions

Internal Hemorrhoids

Interventions

DRUG: Iferanserin
DRUG: Placebo
DRUG: Iferanserin + Placebo

Sponsor

Ventrus Biosciences, Inc